Hubei Heagi Medical Instrument Co., Ltd. – Trademark Portfolio

Entity Type: 99

Hubei Heagi Medical Instrument Co., Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include NURCALM and HEAGIMED. The owner is based in Wuhan.

Asia Plaza, Dandong Road, Jianghan District

Room 1, 10th Floor, Building B

Wuhan 430000 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

NURCALM
NURCALM
Registered 2025
HEAGIMED
HEAGIMED
Registered 2022

Trademark Classifications

Hubei Heagi Medical Instrument Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Hubei Heagi Medical Instrument Co., Ltd. have?

Hubei Heagi Medical Instrument Co., Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Hubei Heagi Medical Instrument Co., Ltd. file in?

Hubei Heagi Medical Instrument Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Hubei Heagi Medical Instrument Co., Ltd.'s most well-known trademarks?

Hubei Heagi Medical Instrument Co., Ltd.'s registered trademark portfolio includes well-known marks such as NURCALM and HEAGIMED. These are among 2 currently registered trademarks in the portfolio.

What is Hubei Heagi Medical Instrument Co., Ltd.'s trademark registration success rate?

Hubei Heagi Medical Instrument Co., Ltd. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.